Visual Evoked Potential Recording in a Rat Model of Experimental Optic Nerve Demyelination.
The visual evoked potential (VEP) recording is widely used in clinical practice to assess the severity of optic neuritis in its acute phase, and to monitor the disease course in the follow-up period. Changes in the VEP parameters closely correlate with pathological damage in the optic nerve. This protocol provides a detailed description about the rodent model of optic nerve microinjection, in which a partial demyelination lesion is produced in the optic nerve. VEP recording techniques are also discussed. Using skull implanted electrodes, we are able to acquire reproducible intra-session and between-session VEP traces. VEPs can be recorded on individual animals over a period of time to assess the functional changes in the optic nerve longitudinally. The optic nerve demyelination model, in conjunction with the VEP recording protocol, provides a tool to investigate the disease processes associated with demyelination and remyelination, and can potentially be employed to evaluate the effects of new remyelinating drugs or neuroprotective therapies.
Department of Ophthalmology, Australian School of Advanced Medicine, Macquarie University; Save Sight Institute, The University of Sydney; yuyi.you@mq.edu.au.
Yuyi
Y
You
Department of Ophthalmology, Australian School of Advanced Medicine, Macquarie University.
Vivek K
VK
Gupta
Department of Ophthalmology, Australian School of Advanced Medicine, Macquarie University.
Nitin
N
Chitranshi
Department of Ophthalmology, Australian School of Advanced Medicine, Macquarie University.
Brittany
B
Reedman
Department of Ophthalmology, Australian School of Advanced Medicine, Macquarie University; Save Sight Institute, The University of Sydney.
Alexander
A
Klistorner
Department of Ophthalmology, Australian School of Advanced Medicine, Macquarie University; Save Sight Institute, The University of Sydney.
Stuart L
SL
Graham
D000818:Animals; D003711:Demyelinating Diseases / Q000473:pathology / Q000503:physiopathology*; D004195:Disease Models, Animal; D018450:Disease Progression; D005074:Evoked Potentials, Visual; D008244:Lysophosphatidylcholines; D008297:Male; D008845:Microinjections; D009900:Optic Nerve / Q000473:pathology / Q000503:physiopathology*; D009902:Optic Neuritis / Q000473:pathology / Q000503:physiopathology; D051381:Rats
D008244:Lysophosphatidylcholines